As a guest user you are not logged in or recognized by your IP address. You have
access to the Front Matter, Abstracts, Author Index, Subject Index and the full
text of Open Access publications.
This chapter describes the negative consequences of medical technology development and commercialization that is too slow, and makes the case for an immediate large scale investment in medical nanorobots to save 52 million lives a year. It also explains the essence of nanotechnology, its life-saving applications, the engineering challenges, and the possibility of 1000-fold improvement over our current human biological abilities. Every decade that we delay development and commercialization of medical nanorobotics, half a billion people perish who could have been saved.
This website uses cookies
We use cookies to provide you with the best possible experience. They also allow us to analyze user behavior in order to constantly improve the website for you. Info about the privacy policy of IOS Press.
This website uses cookies
We use cookies to provide you with the best possible experience. They also allow us to analyze user behavior in order to constantly improve the website for you. Info about the privacy policy of IOS Press.